Medicare 2027
Navigating Medicare AEP 2027:
Key Changes, Costs, and What You Need to Know
The Annual Enrollment Period (AEP) for 2027 runs from October 15 through December 7. Whether you are currently on Original Medicare, a Medicare Advantage plan, or a standalone Part D prescription drug plan, this enrollment window is your annual opportunity to review your current coverage and switch plans for the coming year.
Significant updates driven by federal policy adjustments and the continued rollout of Inflation Reduction Act (IRA) provisions mean that doing nothing could leave money on the table or result in unexpected changes to your doctor network and prescription costs.
Here is a breakdown of the primary changes taking effect for the 2027 plan year and how to prepare.
1. Updated Part D Prescription Drug Caps & Deductibles
The structure of Medicare Part D prescription coverage continues its multi-year evolution:
Part D Out-of-Pocket Cap Adjustments: The annual out-of-pocket maximum for covered Part D prescription drugs adjusts to $2,400 for 2027 (up from $2,100 in 2026). Once your out-of-pocket spending reaches $2,400, you pay $0 for covered Part D prescriptions for the remainder of the calendar year.
Standard Deductible: The maximum allowable Part D deductible rises to $700 for 2027.
No Coverage Gap ("Donut Hole"): The former "donut hole" phase remains permanently eliminated.
Medicare Prescription Payment Plan: You can still opt into spreading your out-of-pocket prescription costs into predictable monthly payments throughout the year rather than paying large amounts at the pharmacy counter all at once.
2. End of Federal Premium Stabilization Buffers (Meaning big changes in drug prices)
A major shift for 2027 is the conclusion of CMS’s temporary Demostration Program.
In 2025 and 2026, the federal government provided a temporary funding buffer to cushion insurers while adapting to major IRA cost caps. With that program ending at the close of 2026, standalone Part D plan pricing is returning to traditional market calculations:
Standalone Part D Premiums: Standalone prescription plan premiums are returning to standard risk pricing. While the base beneficiary premium is set near $41.33 (with 6% statutory caps on base growth), individual standalone plan premiums will vary considerably by carrier and region.
Medicare Advantage Stability: On average, Medicare Advantage plans with prescription coverage (MA-PD) remain stable, with many continuing to offer low or $0 plan premiums.
3. Expanding Medicare-Negotiated Drug Prices
Starting January 1, 2027, 15 additional high-cost medications will have Medicare-negotiated prices taking effect, joining the initial batch of 10 drugs from 2026.
The expanded 2027 list includes widely used brand-name medications such as Ozempic, Rybelsus, and Wegovy, alongside treatments for oncology, respiratory conditions, and autoimmune disorders.
Important Note: A negotiated price reduces overall plan drug costs, but your personal copay or coinsurance still depends on how your specific insurer categorizes that medication on its 2027 formulary (tier placement).
4. Enhanced Network & Benefit Rules for Medicare Advantage
The Centers for Medicare & Medicaid Services (CMS) finalized updated rules aimed at quality and transparency:
Stronger Provider Network Protections: New rules require insurers to provide earlier notification and better transition support if a doctor, specialist, or hospital system leaves a Medicare Advantage network during the year.
Restricted Non-Medical Benefits: CMS has tightened guidelines for Special Supplemental Benefits for the Chronically Ill (SSBCI) to ensure transparency in eligibility criteria and prevent misleading marketing around over-the-counter and stipend allowances.
Star Ratings Shift:
CMS (the government agency running Medicare) updated its 1-to-5 Star Rating system to judge insurance plans more on actual healthcare results rather than paperwork.
Less Focus on Paperwork: Instead of grading plans on back-office tasks (like how fast customer service answers call centers), CMS removed those administrative rules so they no longer boost a plan's score.
More Focus on Actual Health & Mental Care: Scores now heavily depend on how well the plan actually takes care of members—such as ensuring doctors screen patients for depression (and follow up with care) and providing fast access to appointments and medical treatments.
A plan's score now reflects real medical care and patient experience rather than administrative metrics.
Need Guidance?
If you are unsure whether to keep your current plan or explore new options for 2027, call me for unbiased assistance. I am a licensed independent Medicare broker. Jack McGlynn – 407-594-6066